web analytics
10.1 C
Munich
Friday, October 7, 2022

Red Days for GREENHOUSE SOLUTIONS (OTCMKTS:GRSU)

GREENHOUSE SOLUTIONS (OTCMKTS:GRSU) continues to drop in recent weeks on little volume or interest from Investors. The stock popped off its $0.45 base to highs of $0.78 a share in March on a significant promotion.

The Company operates three distinct business units within the burgeoning cannabis market: Greenhouse Solutions’ Design & Consulting Service offers an all-inclusive solution to the expansion and efficiency of hydroponic and agricultural businesses nationwide.

GREENHOUSE SOLUTIONS (OTCMKTS:GRSU) is able to supply a comprehensive solution to the design, build, implementation, production, and expansion of all variations of indoor, outdoor and greenhouse agricultural business; Greenhouse Solutions’ Product Development develops, markets, produces and sells cannabidiol (“CBD”) products for both the personal health and companion pet markets utilizing a licensed probiotic delivery system (US Patent #6,080,401) and other licensed formulas.

Cannabidiol (CBD) is a naturally-occurring substance found in both the cannabis and hemp species of the Cannabis Sativa plant; and Growhouse Solutions acts as a distributor for a variety of equipment, supplies and nutrients for the growhouse industry.

Back in February GRSU announced their plans to manufacture, market and sell a proprietary product for the alleviation of pain in companion animals utilizing Cannabidiols (CBDs) and Probiotics. Greenhouse Solutions previously announced that they were creating products for both the personal health and companion pet markets utilizing a licensed probiotic delivery system (US Patent #6,080,401). Today’s announcement marks the first product to be developed in the Company’s new division that takes advantage of new research in CBD.

To Find out the inside Scoop on GRSU  Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

According to The American Pet Products Association (APPA) there are 83 million dogs and 95 million cats in the US. These companion animals are as susceptible as humans to ailments that require pain-relieving solutions. The total market for companion animals in the US reached an estimated $58.5 billion in 2014. Of these expenditures, over $13 billion was spent on medication for the animals. Additionally, a 2009 survey conducted by Virbac Pharmaceuticals puts the annual US market for companion animal pain relievers at more than $250 million.

CEO Rik J Deitsch said “I have been working with Dr. Reddy to formulate products that utilize the best aspects of the new research and licensed technologies. I’m very excited to get this first product underway as we create new paradigms with the use of Cannabidiols and probiotics for the wellness marketplace,” he continued. “We know that the pain market in companion animals is large and mostly unmet. This will be a necessary product that will make a real difference for millions of pets,” he concluded.

On March 23 GRSU announced their plans to manufacture, market and sell a proprietary product for systemic detoxification utilizing Natural Zeolite, Cannabidiols (CBDs) and Probiotics. Greenhouse Solutions previously announced that they were creating products for both the personal health and companion pet markets utilizing a licensed probiotic delivery system (US Patent #6,080,401). Today’s announcement marks the second product to be developed in the Company’s new division that takes advantage of new research in CBD and their first product for human health.

CEO Rik J Deitsch said I have been working with Natural Zeolites and the concept of systemic detoxification for more than20 years. I’m very excited to utilize this research along with Cannabidiols and probiotics to create a powerful product for the removal of heavy metals and other environmental toxins. We know that everyone has a body burden of these toxins, providing a universal market for this product,”

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $45 million market valuation GRSU has no assets or revenues and rising debt. The Company does operate in the red hot Cannabis space and has been putting out some big press in recent days. GRSU has seen a significant short attack after topping out at $0.78. We will be updating GRSU as events unfold so make sure you are subscribed to Microcapdaily so you know what is going on with GRSU.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in GRSU either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.